18.11.2016
- US federal prosecutors in New York’s Southern District have arrested a former executive of Canada-headquartered Valeant Pharmaceuticals and the former CEO of the erstwhile mail...
14.11.2016
- The California Department of Insurance has issued a subpoena against embattled US drugmaker Valeant Pharmaceuticals over its dealings with specialty pharmacy company Philidor...
03.11.2016
- Valeant Pharmaceuticals is in advanced discussions with Japan’s Takeda to sell its Salix subsidiary for $10 billion, according to the US business newspaper Wall Street Journal. The...
25.08.2016
- Canada-domiciled US drugmaker Valeant has appointed Paul Herendeen, former chief financial officer of Zoetis, to replace its own CFO, Robert Rosiello, as the company struggles to...
07.07.2016
- British-Swedish drugmaker AstraZeneca has formed a strategic partnership with Denmark’s LEO Pharma for skin disease treatments. Under the deal, LEO gains a global license to...
25.04.2016
- In its search for a new CEO to replace William J. Pearson, who has resigned amid several controversies, Canada-domiciled embattled drugmaker Valeant is said to be finalizing a...
14.04.2016
- Michael Pearson, the controversial CEO of Valeant Pharmaceuticals has bowed to pressure and agreed to be deposed by the US Senate’s Special Committee on Aging, which is...
13.04.2016
- The US Senate’s Special Committee on Aging plans to decide on Apr. 13 whether or not to open contempt proceedings against Valeant Pharmaceuticals CEO Michael Pearson. Pearson, who...
